보고서 정보
주관연구기관 |
한국생명공학연구원 Korea Research Institute of Bioscience and Biotechnology |
연구책임자 |
현병환
|
발행국가 | 대한민국 |
언어 |
한국어
|
발행년월 | 2008-04 |
과제시작연도 |
2007 |
주관부처 |
보건복지부 |
사업 관리 기관 |
한국보건산업진흥원 Korea Health Industry Development Institute |
등록번호 |
TRKO200900000100 |
과제고유번호 |
1465008899 |
사업명 |
한방치료기술연구개발 |
DB 구축일자 |
2013-04-18
|
키워드 |
한의약.정책.연구개발.Traditional Medicine.Policy.Research & Development.
|
초록
▼
O 한의약 R&D 중장기 육성 발전 계획
- 한의약의 과학화를 통한 국민건강 증진 및 한방산업 활성화를 위한 3대전략-9대실천과제를 수립
- 관련 부처회람을 통한 의견수렴 및 반영으로 관련 부처 청의 역할과 지원분야 정립
- 정책(R&D 지원체계, 교육, 인프라), 한약 및 치료기술, 진단 및 의료기기 분야별 추진전략, 중점추진 분야, 로드맵 수립
- 한의 약 R&D 중장기 계획기간 동안의 투자규모(총 5,396억원)와 인력 양성 (석박사급 총 8.863명)에 대한 계획 수립
O 한방치료기술연구개발 중장기
O 한의약 R&D 중장기 육성 발전 계획
- 한의약의 과학화를 통한 국민건강 증진 및 한방산업 활성화를 위한 3대전략-9대실천과제를 수립
- 관련 부처회람을 통한 의견수렴 및 반영으로 관련 부처 청의 역할과 지원분야 정립
- 정책(R&D 지원체계, 교육, 인프라), 한약 및 치료기술, 진단 및 의료기기 분야별 추진전략, 중점추진 분야, 로드맵 수립
- 한의 약 R&D 중장기 계획기간 동안의 투자규모(총 5,396억원)와 인력 양성 (석박사급 총 8.863명)에 대한 계획 수립
O 한방치료기술연구개발 중장기 발전계획
- 중장기 계획과 연계하여 사업목표 및 성과지표의 명확화를 위한 사업별 세부목표 수립
- 제품화 세계화 촉진사업, 근거중심 한의학 구축사업, 혁신인프라 지원사업별의 연구분야에 대한 우선추진, 중점추진, 대형과제, 질환별 분야로 체계적인 분류
- 세부사업별 투자규모(총 2,656억원), 연구분야의 실행시기, 로드맵 수립
Abstract
▼
[A planning Study on the long-term growth and Development of Traditional Medicine R&D]
I. Background and History
$\square$ Background
O To promote clinical research to achieve the efficacy and safety of traditional medicine(TM), and to enhance standardization research, as well as
[A planning Study on the long-term growth and Development of Traditional Medicine R&D]
I. Background and History
$\square$ Background
O To promote clinical research to achieve the efficacy and safety of traditional medicine(TM), and to enhance standardization research, as well as to strengthen engagement between research and manufacture.
O To maximize the R&D efficacy of TM by preventing the duplication of R&D investment, and by achieving synergistic effect through the establishment of both effective role allocation among governmental departments and organic supporting system.
$\square$ History
O `07.9.4$\sim$10.14: The Planning Body for Traditional Medicine R&D (PBTM) established a plan to allocate roles of governmental departments and reviewed specific plans(4times)
* PBTM consists of totally 24 members from government, academia, industries, and consumer organizations.
O `07.11.9$\sim$11.30: Deliberation among relevant governmental departments
* MOE, MOST, MAF, MOHW, MPB, KIPO, KFDA, and 16 local organizations
O `07.12.20: Passing in the Review Committee for the Growth and Development of Traditional Medicine
II. Plan for the Long-term Growth and Development of Traditional Medicine R&D
$\square$ Vision, Strategies, and Specific Objectives
O Vision: To improve public health and revitalize TM industries through achieving the scientific evidence of TM
- Objectives: Globalization of TM through achieving scientific evidence, standardization, and the manufacturing of TM
O Strategies
- Strategy 1: Establish the innovative basis of TM R&D
- Strategy 2: Achieve Advanced TM R&D
- Strategy 3: Accelerate the growth of TM industries
O Specific Objectives
- A total of R&D investment (million dollars): 570 ; Patent(#): 224; SCI paper(#): 1187, Standardized clinical treatment protocol(#): 30; Products(#): 51(new drug(4))
$\square$ Allocation of Roles of Governmental Departments
O MOHW : Establish the long-term plan and policy for TM R&D
O MOE : Educate human resources for TM R&D
O MOST : Integrative management of TM R&D programs, basic and applied research, establish public infrastructures for TM R&D
O MAF : Manufacture of TM materials and establish manufacture management system of TM materials
O KFDA : Management of both quality and safety of TM materials and the renovation of relevant regulation.
$\square$ Budget and Human Resources
O Budget (million dollars): 570 (`08$\sim$`17)
O Human resources: 8,863(PhD:3,480, MS:5,383)
[Promotion-planing Study on the TM Treatment and R&D Project]
I. Background and History
$\square$ Background
O To replan the TM Treatment and R&D Project (TMT R&D Project) based on the national long-term plan of TM R&D
O To improve the transparency and efficacy of R&D project by establishing effective plans for TM R&D, industrialization, and infrastructure
$\square$ History
O `07.11$\sim$`08.1: Start replanning TMT R&D Project
O `07.11$\sim$12: Hold committee meetings (3times)
O `07.12$\sim$`08.1: Revision of report by deliberation among commissioners
O `08.2.21: Passing in the Review of Healthcare Policy Committee
II. The Replan of TM Treatment and R&D Project
$\square$ Aim and Objectives
O Aim
- To strengthen the competitiveness of TM by achieving the efficacy and safety of TM and Treatment
- To activate TM clinical research and manufacture by establishing clinical research infra.
- To develop new treatment technology through the collaboration between TM and Western medicine
O Objectives
- Project I: Promoting the manufacture and globalization of TM
- Project II: Establishing evidence-based TM
- Project III: Supporting innovative infra
$\square$ Budget
O Budget(million dollars): 280.6(`08$\sim$`17)
O Project Budget(million dollars): Project I(95.1), Project II(139), Project III(46.5)
목차 Contents
- 제1부 한의약 R&D 중장기 육성.발전 계획...30
- 제2부 한방치료기술개발연구사업 재계획...282
※ AI-Helper는 부적절한 답변을 할 수 있습니다.